Global Peptide Antibiotics Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Peptide Antibiotics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Peptide Antibiotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Peptide Antibiotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Peptide Antibiotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Peptide Antibiotics players cover Pfizer, Novartis, GlaxoSmithKline, Eli Lilly, Theravance, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Peptide Antibiotics Industry Forecast” looks at past sales and reviews total world Peptide Antibiotics sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide Antibiotics sales for 2025 through 2031. With Peptide Antibiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Antibiotics industry.
This Insight Report provides a comprehensive analysis of the global Peptide Antibiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide Antibiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Antibiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Antibiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Antibiotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Antibiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Peptide Antibiotics market?
What factors are driving Peptide Antibiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peptide Antibiotics market opportunities vary by end market size?
How does Peptide Antibiotics break out by Type, by Application?
The global Peptide Antibiotics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Peptide Antibiotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Peptide Antibiotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Peptide Antibiotics is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Peptide Antibiotics players cover Pfizer, Novartis, GlaxoSmithKline, Eli Lilly, Theravance, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Peptide Antibiotics Industry Forecast” looks at past sales and reviews total world Peptide Antibiotics sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide Antibiotics sales for 2025 through 2031. With Peptide Antibiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Antibiotics industry.
This Insight Report provides a comprehensive analysis of the global Peptide Antibiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Peptide Antibiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide Antibiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Antibiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Antibiotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Antibiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Ribosomal Synthesized Peptide Antibiotics
- Non-Ribosomally Synthesized Peptide Antibiotics
- Pharma & Healthcare
- Food Industry
- Commodities
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Novartis
- GlaxoSmithKline
- Eli Lilly
- Theravance
- Vicuron Pharmaceuticals
- Savara Pharmaceuticals
- AMP Therapeutics
- Hospira
- Kasten
- Madam Therapeutics
- Phosphagenics
- Pacgen Life Science Corporation
What is the 10-year outlook for the global Peptide Antibiotics market?
What factors are driving Peptide Antibiotics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Peptide Antibiotics market opportunities vary by end market size?
How does Peptide Antibiotics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide Antibiotics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Peptide Antibiotics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Peptide Antibiotics by Country/Region, 2020, 2024 & 2031
2.2 Peptide Antibiotics Segment by Type
2.2.1 Ribosomal Synthesized Peptide Antibiotics
2.2.2 Non-Ribosomally Synthesized Peptide Antibiotics
2.3 Peptide Antibiotics Sales by Type
2.3.1 Global Peptide Antibiotics Sales Market Share by Type (2020-2025)
2.3.2 Global Peptide Antibiotics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Peptide Antibiotics Sale Price by Type (2020-2025)
2.4 Peptide Antibiotics Segment by Application
2.4.1 Pharma & Healthcare
2.4.2 Food Industry
2.4.3 Commodities
2.4.4 Other
2.5 Peptide Antibiotics Sales by Application
2.5.1 Global Peptide Antibiotics Sale Market Share by Application (2020-2025)
2.5.2 Global Peptide Antibiotics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Peptide Antibiotics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Peptide Antibiotics Breakdown Data by Company
3.1.1 Global Peptide Antibiotics Annual Sales by Company (2020-2025)
3.1.2 Global Peptide Antibiotics Sales Market Share by Company (2020-2025)
3.2 Global Peptide Antibiotics Annual Revenue by Company (2020-2025)
3.2.1 Global Peptide Antibiotics Revenue by Company (2020-2025)
3.2.2 Global Peptide Antibiotics Revenue Market Share by Company (2020-2025)
3.3 Global Peptide Antibiotics Sale Price by Company
3.4 Key Manufacturers Peptide Antibiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peptide Antibiotics Product Location Distribution
3.4.2 Players Peptide Antibiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PEPTIDE ANTIBIOTICS BY GEOGRAPHIC REGION
4.1 World Historic Peptide Antibiotics Market Size by Geographic Region (2020-2025)
4.1.1 Global Peptide Antibiotics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Peptide Antibiotics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Peptide Antibiotics Market Size by Country/Region (2020-2025)
4.2.1 Global Peptide Antibiotics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Peptide Antibiotics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide Antibiotics Sales Growth
4.4 APAC Peptide Antibiotics Sales Growth
4.5 Europe Peptide Antibiotics Sales Growth
4.6 Middle East & Africa Peptide Antibiotics Sales Growth
5 AMERICAS
5.1 Americas Peptide Antibiotics Sales by Country
5.1.1 Americas Peptide Antibiotics Sales by Country (2020-2025)
5.1.2 Americas Peptide Antibiotics Revenue by Country (2020-2025)
5.2 Americas Peptide Antibiotics Sales by Type (2020-2025)
5.3 Americas Peptide Antibiotics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Antibiotics Sales by Region
6.1.1 APAC Peptide Antibiotics Sales by Region (2020-2025)
6.1.2 APAC Peptide Antibiotics Revenue by Region (2020-2025)
6.2 APAC Peptide Antibiotics Sales by Type (2020-2025)
6.3 APAC Peptide Antibiotics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peptide Antibiotics by Country
7.1.1 Europe Peptide Antibiotics Sales by Country (2020-2025)
7.1.2 Europe Peptide Antibiotics Revenue by Country (2020-2025)
7.2 Europe Peptide Antibiotics Sales by Type (2020-2025)
7.3 Europe Peptide Antibiotics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide Antibiotics by Country
8.1.1 Middle East & Africa Peptide Antibiotics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Peptide Antibiotics Revenue by Country (2020-2025)
8.2 Middle East & Africa Peptide Antibiotics Sales by Type (2020-2025)
8.3 Middle East & Africa Peptide Antibiotics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peptide Antibiotics
10.3 Manufacturing Process Analysis of Peptide Antibiotics
10.4 Industry Chain Structure of Peptide Antibiotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peptide Antibiotics Distributors
11.3 Peptide Antibiotics Customer
12 WORLD FORECAST REVIEW FOR PEPTIDE ANTIBIOTICS BY GEOGRAPHIC REGION
12.1 Global Peptide Antibiotics Market Size Forecast by Region
12.1.1 Global Peptide Antibiotics Forecast by Region (2026-2031)
12.1.2 Global Peptide Antibiotics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Peptide Antibiotics Forecast by Type (2026-2031)
12.7 Global Peptide Antibiotics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Peptide Antibiotics Product Portfolios and Specifications
13.1.3 Pfizer Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Peptide Antibiotics Product Portfolios and Specifications
13.2.3 Novartis Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Peptide Antibiotics Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly Peptide Antibiotics Product Portfolios and Specifications
13.4.3 Eli Lilly Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 Theravance
13.5.1 Theravance Company Information
13.5.2 Theravance Peptide Antibiotics Product Portfolios and Specifications
13.5.3 Theravance Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Theravance Main Business Overview
13.5.5 Theravance Latest Developments
13.6 Vicuron Pharmaceuticals
13.6.1 Vicuron Pharmaceuticals Company Information
13.6.2 Vicuron Pharmaceuticals Peptide Antibiotics Product Portfolios and Specifications
13.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Vicuron Pharmaceuticals Main Business Overview
13.6.5 Vicuron Pharmaceuticals Latest Developments
13.7 Savara Pharmaceuticals
13.7.1 Savara Pharmaceuticals Company Information
13.7.2 Savara Pharmaceuticals Peptide Antibiotics Product Portfolios and Specifications
13.7.3 Savara Pharmaceuticals Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Savara Pharmaceuticals Main Business Overview
13.7.5 Savara Pharmaceuticals Latest Developments
13.8 AMP Therapeutics
13.8.1 AMP Therapeutics Company Information
13.8.2 AMP Therapeutics Peptide Antibiotics Product Portfolios and Specifications
13.8.3 AMP Therapeutics Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 AMP Therapeutics Main Business Overview
13.8.5 AMP Therapeutics Latest Developments
13.9 Hospira
13.9.1 Hospira Company Information
13.9.2 Hospira Peptide Antibiotics Product Portfolios and Specifications
13.9.3 Hospira Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hospira Main Business Overview
13.9.5 Hospira Latest Developments
13.10 Kasten
13.10.1 Kasten Company Information
13.10.2 Kasten Peptide Antibiotics Product Portfolios and Specifications
13.10.3 Kasten Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Kasten Main Business Overview
13.10.5 Kasten Latest Developments
13.11 Madam Therapeutics
13.11.1 Madam Therapeutics Company Information
13.11.2 Madam Therapeutics Peptide Antibiotics Product Portfolios and Specifications
13.11.3 Madam Therapeutics Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Madam Therapeutics Main Business Overview
13.11.5 Madam Therapeutics Latest Developments
13.12 Phosphagenics
13.12.1 Phosphagenics Company Information
13.12.2 Phosphagenics Peptide Antibiotics Product Portfolios and Specifications
13.12.3 Phosphagenics Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Phosphagenics Main Business Overview
13.12.5 Phosphagenics Latest Developments
13.13 Pacgen Life Science Corporation
13.13.1 Pacgen Life Science Corporation Company Information
13.13.2 Pacgen Life Science Corporation Peptide Antibiotics Product Portfolios and Specifications
13.13.3 Pacgen Life Science Corporation Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Pacgen Life Science Corporation Main Business Overview
13.13.5 Pacgen Life Science Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Peptide Antibiotics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Peptide Antibiotics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ribosomal Synthesized Peptide Antibiotics
Table 4. Major Players of Non-Ribosomally Synthesized Peptide Antibiotics
Table 5. Global Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 6. Global Peptide Antibiotics Sales Market Share byType (2020-2025)
Table 7. Global Peptide Antibiotics Revenue byType (2020-2025) & ($ million)
Table 8. Global Peptide Antibiotics Revenue Market Share byType (2020-2025)
Table 9. Global Peptide Antibiotics Sale Price byType (2020-2025) & (USD/Kg)
Table 10. Global Peptide Antibiotics Sale by Application (2020-2025) & (MT)
Table 11. Global Peptide Antibiotics Sale Market Share by Application (2020-2025)
Table 12. Global Peptide Antibiotics Revenue by Application (2020-2025) & ($ million)
Table 13. Global Peptide Antibiotics Revenue Market Share by Application (2020-2025)
Table 14. Global Peptide Antibiotics Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Peptide Antibiotics Sales by Company (2020-2025) & (MT)
Table 16. Global Peptide Antibiotics Sales Market Share by Company (2020-2025)
Table 17. Global Peptide Antibiotics Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Peptide Antibiotics Revenue Market Share by Company (2020-2025)
Table 19. Global Peptide Antibiotics Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Peptide Antibiotics Producing Area Distribution and Sales Area
Table 21. Players Peptide Antibiotics Products Offered
Table 22. Peptide Antibiotics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Peptide Antibiotics Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Peptide Antibiotics Sales Market Share Geographic Region (2020-2025)
Table 27. Global Peptide Antibiotics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Peptide Antibiotics Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Peptide Antibiotics Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Peptide Antibiotics Sales Market Share by Country/Region (2020-2025)
Table 31. Global Peptide Antibiotics Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Peptide Antibiotics Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 34. Americas Peptide Antibiotics Sales Market Share by Country (2020-2025)
Table 35. Americas Peptide Antibiotics Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 37. Americas Peptide Antibiotics Sales by Application (2020-2025) & (MT)
Table 38. APAC Peptide Antibiotics Sales by Region (2020-2025) & (MT)
Table 39. APAC Peptide Antibiotics Sales Market Share by Region (2020-2025)
Table 40. APAC Peptide Antibiotics Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 42. APAC Peptide Antibiotics Sales by Application (2020-2025) & (MT)
Table 43. Europe Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 44. Europe Peptide Antibiotics Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 46. Europe Peptide Antibiotics Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Peptide Antibiotics Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Peptide Antibiotics Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Peptide Antibiotics
Table 52. Key Market Challenges & Risks of Peptide Antibiotics
Table 53. Key IndustryTrends of Peptide Antibiotics
Table 54. Peptide Antibiotics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Peptide Antibiotics Distributors List
Table 57. Peptide Antibiotics Customer List
Table 58. Global Peptide Antibiotics SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Peptide Antibiotics RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Peptide Antibiotics SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Peptide Antibiotics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Peptide Antibiotics SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Peptide Antibiotics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Peptide Antibiotics SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Peptide Antibiotics RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Peptide Antibiotics SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Peptide Antibiotics RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Peptide Antibiotics SalesForecast byType (2026-2031) & (MT)
Table 69. Global Peptide Antibiotics RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Peptide Antibiotics SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Peptide Antibiotics RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Peptide Antibiotics Product Portfolios and Specifications
Table 74. Pfizer Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Novartis Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis Peptide Antibiotics Product Portfolios and Specifications
Table 79. Novartis Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. GlaxoSmithKline Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline Peptide Antibiotics Product Portfolios and Specifications
Table 84. GlaxoSmithKline Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. GlaxoSmithKline Main Business
Table 86. GlaxoSmithKline Latest Developments
Table 87. Eli Lilly Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 88. Eli Lilly Peptide Antibiotics Product Portfolios and Specifications
Table 89. Eli Lilly Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Eli Lilly Main Business
Table 91. Eli Lilly Latest Developments
Table 92.Theravance Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 93.Theravance Peptide Antibiotics Product Portfolios and Specifications
Table 94.Theravance Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95.Theravance Main Business
Table 96.Theravance Latest Developments
Table 97. Vicuron Pharmaceuticals Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 98. Vicuron Pharmaceuticals Peptide Antibiotics Product Portfolios and Specifications
Table 99. Vicuron Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. Vicuron Pharmaceuticals Main Business
Table 101. Vicuron Pharmaceuticals Latest Developments
Table 102. Savara Pharmaceuticals Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 103. Savara Pharmaceuticals Peptide Antibiotics Product Portfolios and Specifications
Table 104. Savara Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Savara Pharmaceuticals Main Business
Table 106. Savara Pharmaceuticals Latest Developments
Table 107. AMPTherapeutics Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 108. AMPTherapeutics Peptide Antibiotics Product Portfolios and Specifications
Table 109. AMPTherapeutics Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. AMPTherapeutics Main Business
Table 111. AMPTherapeutics Latest Developments
Table 112. Hospira Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 113. Hospira Peptide Antibiotics Product Portfolios and Specifications
Table 114. Hospira Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. Hospira Main Business
Table 116. Hospira Latest Developments
Table 117. Kasten Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 118. Kasten Peptide Antibiotics Product Portfolios and Specifications
Table 119. Kasten Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Kasten Main Business
Table 121. Kasten Latest Developments
Table 122. MadamTherapeutics Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 123. MadamTherapeutics Peptide Antibiotics Product Portfolios and Specifications
Table 124. MadamTherapeutics Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. MadamTherapeutics Main Business
Table 126. MadamTherapeutics Latest Developments
Table 127. Phosphagenics Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 128. Phosphagenics Peptide Antibiotics Product Portfolios and Specifications
Table 129. Phosphagenics Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Phosphagenics Main Business
Table 131. Phosphagenics Latest Developments
Table 132. Pacgen Life Science Corporation Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 133. Pacgen Life Science Corporation Peptide Antibiotics Product Portfolios and Specifications
Table 134. Pacgen Life Science Corporation Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 135. Pacgen Life Science Corporation Main Business
Table 136. Pacgen Life Science Corporation Latest Developments
LIST OFFIGURES
Figure 1. Picture of Peptide Antibiotics
Figure 2. Peptide Antibiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peptide Antibiotics Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Peptide Antibiotics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Peptide Antibiotics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Peptide Antibiotics Sales Market Share by Country/Region (2024)
Figure 10. Peptide Antibiotics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Ribosomal Synthesized Peptide Antibiotics
Figure 12. Product Picture of Non-Ribosomally Synthesized Peptide Antibiotics
Figure 13. Global Peptide Antibiotics Sales Market Share byType in 2025
Figure 14. Global Peptide Antibiotics Revenue Market Share byType (2020-2025)
Figure 15. Peptide Antibiotics Consumed in Pharma & Healthcare
Figure 16. Global Peptide Antibiotics Market: Pharma & Healthcare (2020-2025) & (MT)
Figure 17. Peptide Antibiotics Consumed inFood Industry
Figure 18. Global Peptide Antibiotics Market:Food Industry (2020-2025) & (MT)
Figure 19. Peptide Antibiotics Consumed in Commodities
Figure 20. Global Peptide Antibiotics Market: Commodities (2020-2025) & (MT)
Figure 21. Peptide Antibiotics Consumed in Other
Figure 22. Global Peptide Antibiotics Market: Other (2020-2025) & (MT)
Figure 23. Global Peptide Antibiotics Sale Market Share by Application (2024)
Figure 24. Global Peptide Antibiotics Revenue Market Share by Application in 2025
Figure 25. Peptide Antibiotics Sales by Company in 2025 (MT)
Figure 26. Global Peptide Antibiotics Sales Market Share by Company in 2025
Figure 27. Peptide Antibiotics Revenue by Company in 2025 ($ millions)
Figure 28. Global Peptide Antibiotics Revenue Market Share by Company in 2025
Figure 29. Global Peptide Antibiotics Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Peptide Antibiotics Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Peptide Antibiotics Sales 2020-2025 (MT)
Figure 32. Americas Peptide Antibiotics Revenue 2020-2025 ($ millions)
Figure 33. APAC Peptide Antibiotics Sales 2020-2025 (MT)
Figure 34. APAC Peptide Antibiotics Revenue 2020-2025 ($ millions)
Figure 35. Europe Peptide Antibiotics Sales 2020-2025 (MT)
Figure 36. Europe Peptide Antibiotics Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Peptide Antibiotics Sales 2020-2025 (MT)
Figure 38. Middle East & Africa Peptide Antibiotics Revenue 2020-2025 ($ millions)
Figure 39. Americas Peptide Antibiotics Sales Market Share by Country in 2025
Figure 40. Americas Peptide Antibiotics Revenue Market Share by Country (2020-2025)
Figure 41. Americas Peptide Antibiotics Sales Market Share byType (2020-2025)
Figure 42. Americas Peptide Antibiotics Sales Market Share by Application (2020-2025)
Figure 43. United States Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Peptide Antibiotics Sales Market Share by Region in 2025
Figure 48. APAC Peptide Antibiotics Revenue Market Share by Region (2020-2025)
Figure 49. APAC Peptide Antibiotics Sales Market Share byType (2020-2025)
Figure 50. APAC Peptide Antibiotics Sales Market Share by Application (2020-2025)
Figure 51. China Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 55. India Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Peptide Antibiotics Sales Market Share by Country in 2025
Figure 59. Europe Peptide Antibiotics Revenue Market Share by Country (2020-2025)
Figure 60. Europe Peptide Antibiotics Sales Market Share byType (2020-2025)
Figure 61. Europe Peptide Antibiotics Sales Market Share by Application (2020-2025)
Figure 62. Germany Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 63.France Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Peptide Antibiotics Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Peptide Antibiotics Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Peptide Antibiotics Sales Market Share by Application (2020-2025)
Figure 70. Egypt Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Peptide Antibiotics in 2025
Figure 76. Manufacturing Process Analysis of Peptide Antibiotics
Figure 77. Industry Chain Structure of Peptide Antibiotics
Figure 78. Channels of Distribution
Figure 79. Global Peptide Antibiotics Sales MarketForecast by Region (2026-2031)
Figure 80. Global Peptide Antibiotics Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Peptide Antibiotics Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Peptide Antibiotics Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Peptide Antibiotics Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Peptide Antibiotics Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Peptide Antibiotics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Peptide Antibiotics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Peptide Antibiotics by Country/Region, 2020, 2024 & 2031
2.2 Peptide Antibiotics Segment by Type
2.2.1 Ribosomal Synthesized Peptide Antibiotics
2.2.2 Non-Ribosomally Synthesized Peptide Antibiotics
2.3 Peptide Antibiotics Sales by Type
2.3.1 Global Peptide Antibiotics Sales Market Share by Type (2020-2025)
2.3.2 Global Peptide Antibiotics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Peptide Antibiotics Sale Price by Type (2020-2025)
2.4 Peptide Antibiotics Segment by Application
2.4.1 Pharma & Healthcare
2.4.2 Food Industry
2.4.3 Commodities
2.4.4 Other
2.5 Peptide Antibiotics Sales by Application
2.5.1 Global Peptide Antibiotics Sale Market Share by Application (2020-2025)
2.5.2 Global Peptide Antibiotics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Peptide Antibiotics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Peptide Antibiotics Breakdown Data by Company
3.1.1 Global Peptide Antibiotics Annual Sales by Company (2020-2025)
3.1.2 Global Peptide Antibiotics Sales Market Share by Company (2020-2025)
3.2 Global Peptide Antibiotics Annual Revenue by Company (2020-2025)
3.2.1 Global Peptide Antibiotics Revenue by Company (2020-2025)
3.2.2 Global Peptide Antibiotics Revenue Market Share by Company (2020-2025)
3.3 Global Peptide Antibiotics Sale Price by Company
3.4 Key Manufacturers Peptide Antibiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peptide Antibiotics Product Location Distribution
3.4.2 Players Peptide Antibiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PEPTIDE ANTIBIOTICS BY GEOGRAPHIC REGION
4.1 World Historic Peptide Antibiotics Market Size by Geographic Region (2020-2025)
4.1.1 Global Peptide Antibiotics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Peptide Antibiotics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Peptide Antibiotics Market Size by Country/Region (2020-2025)
4.2.1 Global Peptide Antibiotics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Peptide Antibiotics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide Antibiotics Sales Growth
4.4 APAC Peptide Antibiotics Sales Growth
4.5 Europe Peptide Antibiotics Sales Growth
4.6 Middle East & Africa Peptide Antibiotics Sales Growth
5 AMERICAS
5.1 Americas Peptide Antibiotics Sales by Country
5.1.1 Americas Peptide Antibiotics Sales by Country (2020-2025)
5.1.2 Americas Peptide Antibiotics Revenue by Country (2020-2025)
5.2 Americas Peptide Antibiotics Sales by Type (2020-2025)
5.3 Americas Peptide Antibiotics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Antibiotics Sales by Region
6.1.1 APAC Peptide Antibiotics Sales by Region (2020-2025)
6.1.2 APAC Peptide Antibiotics Revenue by Region (2020-2025)
6.2 APAC Peptide Antibiotics Sales by Type (2020-2025)
6.3 APAC Peptide Antibiotics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Peptide Antibiotics by Country
7.1.1 Europe Peptide Antibiotics Sales by Country (2020-2025)
7.1.2 Europe Peptide Antibiotics Revenue by Country (2020-2025)
7.2 Europe Peptide Antibiotics Sales by Type (2020-2025)
7.3 Europe Peptide Antibiotics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Peptide Antibiotics by Country
8.1.1 Middle East & Africa Peptide Antibiotics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Peptide Antibiotics Revenue by Country (2020-2025)
8.2 Middle East & Africa Peptide Antibiotics Sales by Type (2020-2025)
8.3 Middle East & Africa Peptide Antibiotics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peptide Antibiotics
10.3 Manufacturing Process Analysis of Peptide Antibiotics
10.4 Industry Chain Structure of Peptide Antibiotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peptide Antibiotics Distributors
11.3 Peptide Antibiotics Customer
12 WORLD FORECAST REVIEW FOR PEPTIDE ANTIBIOTICS BY GEOGRAPHIC REGION
12.1 Global Peptide Antibiotics Market Size Forecast by Region
12.1.1 Global Peptide Antibiotics Forecast by Region (2026-2031)
12.1.2 Global Peptide Antibiotics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Peptide Antibiotics Forecast by Type (2026-2031)
12.7 Global Peptide Antibiotics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Peptide Antibiotics Product Portfolios and Specifications
13.1.3 Pfizer Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Peptide Antibiotics Product Portfolios and Specifications
13.2.3 Novartis Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Information
13.3.2 GlaxoSmithKline Peptide Antibiotics Product Portfolios and Specifications
13.3.3 GlaxoSmithKline Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GlaxoSmithKline Main Business Overview
13.3.5 GlaxoSmithKline Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly Peptide Antibiotics Product Portfolios and Specifications
13.4.3 Eli Lilly Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 Theravance
13.5.1 Theravance Company Information
13.5.2 Theravance Peptide Antibiotics Product Portfolios and Specifications
13.5.3 Theravance Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Theravance Main Business Overview
13.5.5 Theravance Latest Developments
13.6 Vicuron Pharmaceuticals
13.6.1 Vicuron Pharmaceuticals Company Information
13.6.2 Vicuron Pharmaceuticals Peptide Antibiotics Product Portfolios and Specifications
13.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Vicuron Pharmaceuticals Main Business Overview
13.6.5 Vicuron Pharmaceuticals Latest Developments
13.7 Savara Pharmaceuticals
13.7.1 Savara Pharmaceuticals Company Information
13.7.2 Savara Pharmaceuticals Peptide Antibiotics Product Portfolios and Specifications
13.7.3 Savara Pharmaceuticals Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Savara Pharmaceuticals Main Business Overview
13.7.5 Savara Pharmaceuticals Latest Developments
13.8 AMP Therapeutics
13.8.1 AMP Therapeutics Company Information
13.8.2 AMP Therapeutics Peptide Antibiotics Product Portfolios and Specifications
13.8.3 AMP Therapeutics Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 AMP Therapeutics Main Business Overview
13.8.5 AMP Therapeutics Latest Developments
13.9 Hospira
13.9.1 Hospira Company Information
13.9.2 Hospira Peptide Antibiotics Product Portfolios and Specifications
13.9.3 Hospira Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Hospira Main Business Overview
13.9.5 Hospira Latest Developments
13.10 Kasten
13.10.1 Kasten Company Information
13.10.2 Kasten Peptide Antibiotics Product Portfolios and Specifications
13.10.3 Kasten Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Kasten Main Business Overview
13.10.5 Kasten Latest Developments
13.11 Madam Therapeutics
13.11.1 Madam Therapeutics Company Information
13.11.2 Madam Therapeutics Peptide Antibiotics Product Portfolios and Specifications
13.11.3 Madam Therapeutics Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Madam Therapeutics Main Business Overview
13.11.5 Madam Therapeutics Latest Developments
13.12 Phosphagenics
13.12.1 Phosphagenics Company Information
13.12.2 Phosphagenics Peptide Antibiotics Product Portfolios and Specifications
13.12.3 Phosphagenics Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Phosphagenics Main Business Overview
13.12.5 Phosphagenics Latest Developments
13.13 Pacgen Life Science Corporation
13.13.1 Pacgen Life Science Corporation Company Information
13.13.2 Pacgen Life Science Corporation Peptide Antibiotics Product Portfolios and Specifications
13.13.3 Pacgen Life Science Corporation Peptide Antibiotics Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Pacgen Life Science Corporation Main Business Overview
13.13.5 Pacgen Life Science Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Peptide Antibiotics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Peptide Antibiotics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Ribosomal Synthesized Peptide Antibiotics
Table 4. Major Players of Non-Ribosomally Synthesized Peptide Antibiotics
Table 5. Global Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 6. Global Peptide Antibiotics Sales Market Share byType (2020-2025)
Table 7. Global Peptide Antibiotics Revenue byType (2020-2025) & ($ million)
Table 8. Global Peptide Antibiotics Revenue Market Share byType (2020-2025)
Table 9. Global Peptide Antibiotics Sale Price byType (2020-2025) & (USD/Kg)
Table 10. Global Peptide Antibiotics Sale by Application (2020-2025) & (MT)
Table 11. Global Peptide Antibiotics Sale Market Share by Application (2020-2025)
Table 12. Global Peptide Antibiotics Revenue by Application (2020-2025) & ($ million)
Table 13. Global Peptide Antibiotics Revenue Market Share by Application (2020-2025)
Table 14. Global Peptide Antibiotics Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Peptide Antibiotics Sales by Company (2020-2025) & (MT)
Table 16. Global Peptide Antibiotics Sales Market Share by Company (2020-2025)
Table 17. Global Peptide Antibiotics Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Peptide Antibiotics Revenue Market Share by Company (2020-2025)
Table 19. Global Peptide Antibiotics Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Peptide Antibiotics Producing Area Distribution and Sales Area
Table 21. Players Peptide Antibiotics Products Offered
Table 22. Peptide Antibiotics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Peptide Antibiotics Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Peptide Antibiotics Sales Market Share Geographic Region (2020-2025)
Table 27. Global Peptide Antibiotics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Peptide Antibiotics Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Peptide Antibiotics Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Peptide Antibiotics Sales Market Share by Country/Region (2020-2025)
Table 31. Global Peptide Antibiotics Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Peptide Antibiotics Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 34. Americas Peptide Antibiotics Sales Market Share by Country (2020-2025)
Table 35. Americas Peptide Antibiotics Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 37. Americas Peptide Antibiotics Sales by Application (2020-2025) & (MT)
Table 38. APAC Peptide Antibiotics Sales by Region (2020-2025) & (MT)
Table 39. APAC Peptide Antibiotics Sales Market Share by Region (2020-2025)
Table 40. APAC Peptide Antibiotics Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 42. APAC Peptide Antibiotics Sales by Application (2020-2025) & (MT)
Table 43. Europe Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 44. Europe Peptide Antibiotics Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 46. Europe Peptide Antibiotics Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Peptide Antibiotics Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Peptide Antibiotics Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Peptide Antibiotics Sales byType (2020-2025) & (MT)
Table 50. Middle East & Africa Peptide Antibiotics Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Peptide Antibiotics
Table 52. Key Market Challenges & Risks of Peptide Antibiotics
Table 53. Key IndustryTrends of Peptide Antibiotics
Table 54. Peptide Antibiotics Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Peptide Antibiotics Distributors List
Table 57. Peptide Antibiotics Customer List
Table 58. Global Peptide Antibiotics SalesForecast by Region (2026-2031) & (MT)
Table 59. Global Peptide Antibiotics RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Peptide Antibiotics SalesForecast by Country (2026-2031) & (MT)
Table 61. Americas Peptide Antibiotics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Peptide Antibiotics SalesForecast by Region (2026-2031) & (MT)
Table 63. APAC Peptide Antibiotics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Peptide Antibiotics SalesForecast by Country (2026-2031) & (MT)
Table 65. Europe Peptide Antibiotics RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Peptide Antibiotics SalesForecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Peptide Antibiotics RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Peptide Antibiotics SalesForecast byType (2026-2031) & (MT)
Table 69. Global Peptide Antibiotics RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Peptide Antibiotics SalesForecast by Application (2026-2031) & (MT)
Table 71. Global Peptide Antibiotics RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Peptide Antibiotics Product Portfolios and Specifications
Table 74. Pfizer Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Novartis Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 78. Novartis Peptide Antibiotics Product Portfolios and Specifications
Table 79. Novartis Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. Novartis Main Business
Table 81. Novartis Latest Developments
Table 82. GlaxoSmithKline Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 83. GlaxoSmithKline Peptide Antibiotics Product Portfolios and Specifications
Table 84. GlaxoSmithKline Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. GlaxoSmithKline Main Business
Table 86. GlaxoSmithKline Latest Developments
Table 87. Eli Lilly Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 88. Eli Lilly Peptide Antibiotics Product Portfolios and Specifications
Table 89. Eli Lilly Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Eli Lilly Main Business
Table 91. Eli Lilly Latest Developments
Table 92.Theravance Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 93.Theravance Peptide Antibiotics Product Portfolios and Specifications
Table 94.Theravance Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95.Theravance Main Business
Table 96.Theravance Latest Developments
Table 97. Vicuron Pharmaceuticals Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 98. Vicuron Pharmaceuticals Peptide Antibiotics Product Portfolios and Specifications
Table 99. Vicuron Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. Vicuron Pharmaceuticals Main Business
Table 101. Vicuron Pharmaceuticals Latest Developments
Table 102. Savara Pharmaceuticals Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 103. Savara Pharmaceuticals Peptide Antibiotics Product Portfolios and Specifications
Table 104. Savara Pharmaceuticals Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Savara Pharmaceuticals Main Business
Table 106. Savara Pharmaceuticals Latest Developments
Table 107. AMPTherapeutics Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 108. AMPTherapeutics Peptide Antibiotics Product Portfolios and Specifications
Table 109. AMPTherapeutics Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. AMPTherapeutics Main Business
Table 111. AMPTherapeutics Latest Developments
Table 112. Hospira Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 113. Hospira Peptide Antibiotics Product Portfolios and Specifications
Table 114. Hospira Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. Hospira Main Business
Table 116. Hospira Latest Developments
Table 117. Kasten Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 118. Kasten Peptide Antibiotics Product Portfolios and Specifications
Table 119. Kasten Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Kasten Main Business
Table 121. Kasten Latest Developments
Table 122. MadamTherapeutics Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 123. MadamTherapeutics Peptide Antibiotics Product Portfolios and Specifications
Table 124. MadamTherapeutics Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. MadamTherapeutics Main Business
Table 126. MadamTherapeutics Latest Developments
Table 127. Phosphagenics Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 128. Phosphagenics Peptide Antibiotics Product Portfolios and Specifications
Table 129. Phosphagenics Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Phosphagenics Main Business
Table 131. Phosphagenics Latest Developments
Table 132. Pacgen Life Science Corporation Basic Information, Peptide Antibiotics Manufacturing Base, Sales Area and Its Competitors
Table 133. Pacgen Life Science Corporation Peptide Antibiotics Product Portfolios and Specifications
Table 134. Pacgen Life Science Corporation Peptide Antibiotics Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 135. Pacgen Life Science Corporation Main Business
Table 136. Pacgen Life Science Corporation Latest Developments
LIST OFFIGURES
Figure 1. Picture of Peptide Antibiotics
Figure 2. Peptide Antibiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peptide Antibiotics Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Peptide Antibiotics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Peptide Antibiotics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Peptide Antibiotics Sales Market Share by Country/Region (2024)
Figure 10. Peptide Antibiotics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Ribosomal Synthesized Peptide Antibiotics
Figure 12. Product Picture of Non-Ribosomally Synthesized Peptide Antibiotics
Figure 13. Global Peptide Antibiotics Sales Market Share byType in 2025
Figure 14. Global Peptide Antibiotics Revenue Market Share byType (2020-2025)
Figure 15. Peptide Antibiotics Consumed in Pharma & Healthcare
Figure 16. Global Peptide Antibiotics Market: Pharma & Healthcare (2020-2025) & (MT)
Figure 17. Peptide Antibiotics Consumed inFood Industry
Figure 18. Global Peptide Antibiotics Market:Food Industry (2020-2025) & (MT)
Figure 19. Peptide Antibiotics Consumed in Commodities
Figure 20. Global Peptide Antibiotics Market: Commodities (2020-2025) & (MT)
Figure 21. Peptide Antibiotics Consumed in Other
Figure 22. Global Peptide Antibiotics Market: Other (2020-2025) & (MT)
Figure 23. Global Peptide Antibiotics Sale Market Share by Application (2024)
Figure 24. Global Peptide Antibiotics Revenue Market Share by Application in 2025
Figure 25. Peptide Antibiotics Sales by Company in 2025 (MT)
Figure 26. Global Peptide Antibiotics Sales Market Share by Company in 2025
Figure 27. Peptide Antibiotics Revenue by Company in 2025 ($ millions)
Figure 28. Global Peptide Antibiotics Revenue Market Share by Company in 2025
Figure 29. Global Peptide Antibiotics Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Peptide Antibiotics Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Peptide Antibiotics Sales 2020-2025 (MT)
Figure 32. Americas Peptide Antibiotics Revenue 2020-2025 ($ millions)
Figure 33. APAC Peptide Antibiotics Sales 2020-2025 (MT)
Figure 34. APAC Peptide Antibiotics Revenue 2020-2025 ($ millions)
Figure 35. Europe Peptide Antibiotics Sales 2020-2025 (MT)
Figure 36. Europe Peptide Antibiotics Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Peptide Antibiotics Sales 2020-2025 (MT)
Figure 38. Middle East & Africa Peptide Antibiotics Revenue 2020-2025 ($ millions)
Figure 39. Americas Peptide Antibiotics Sales Market Share by Country in 2025
Figure 40. Americas Peptide Antibiotics Revenue Market Share by Country (2020-2025)
Figure 41. Americas Peptide Antibiotics Sales Market Share byType (2020-2025)
Figure 42. Americas Peptide Antibiotics Sales Market Share by Application (2020-2025)
Figure 43. United States Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Peptide Antibiotics Sales Market Share by Region in 2025
Figure 48. APAC Peptide Antibiotics Revenue Market Share by Region (2020-2025)
Figure 49. APAC Peptide Antibiotics Sales Market Share byType (2020-2025)
Figure 50. APAC Peptide Antibiotics Sales Market Share by Application (2020-2025)
Figure 51. China Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 55. India Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Peptide Antibiotics Sales Market Share by Country in 2025
Figure 59. Europe Peptide Antibiotics Revenue Market Share by Country (2020-2025)
Figure 60. Europe Peptide Antibiotics Sales Market Share byType (2020-2025)
Figure 61. Europe Peptide Antibiotics Sales Market Share by Application (2020-2025)
Figure 62. Germany Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 63.France Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Peptide Antibiotics Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Peptide Antibiotics Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Peptide Antibiotics Sales Market Share by Application (2020-2025)
Figure 70. Egypt Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Peptide Antibiotics Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Peptide Antibiotics in 2025
Figure 76. Manufacturing Process Analysis of Peptide Antibiotics
Figure 77. Industry Chain Structure of Peptide Antibiotics
Figure 78. Channels of Distribution
Figure 79. Global Peptide Antibiotics Sales MarketForecast by Region (2026-2031)
Figure 80. Global Peptide Antibiotics Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Peptide Antibiotics Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Peptide Antibiotics Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Peptide Antibiotics Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Peptide Antibiotics Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Petri Dishes Market Growth 2025-2031
US$ 3,660.00
March 2025
167 pages
Global Cell Culture Cryoware Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
November 2024
109 pages
Global Human Oral Vaccine Market Growth 2024-2030
US$ 3,660.00
June 2024
142 pages
Global Veterinary PoC Diagnostics Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
101 pages
Global Medical Cabinets & Utensils Market Growth 2025-2031
US$ 3,660.00
January 2024
87 pages
